Data Registry in Chinese Hemophilia A and B Patients

Institute of Hematology & Blood Diseases Hospital, China

Status: Completed

Conditions: Hemophilia B; Hemophilia A

Study type: Observational

Funder types: Other

Identifiers

NCT07101224

QT2016004

Details and patient eligibility

About

This is an open-label, prospective, multi-center, patient registry in Chinese Hemophilia A and B patients treated with anti-hemophilic coagulation factor replacement therapy.

Enrollment: 200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria：

Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the study:

1. Hemophilia A and Hemophilia B patient diagnosed;
2. Taking anti-hemophilic coagulation factor replacement therapy during the 2 year registry period.

Exclusion Criteria:

1. Unwilling or unable to follow the terms of the protocol.

Trial design

200 participants in 2 patient groups

Hemophilia A

Hemophilia B